Hangzhou Tigermed Consulting Co., Ltd (300347.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 48.41B |
| Enterprise Value | 48.1B |
| P/E Ratio | 660 |
| PEG Ratio | -8.63 |
| Price/Sales Ratio | 5.34 |
| Price/Book Ratio | 2.27 |
| Enterprise/Revenue | 5.39 |
| Enterprise/EBITDA | 25.64 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.01 |
| Operating Margin | 0.16 |
| Return On Assets | 0 |
| Return On Equity | 0 |
| Revenue | 6.83B |
| Revenue/Share | 8.72 |
| Gross Profit | 1.87B |
| EBITDA | 820.3M |
| Net Income | 887.89M |
| Diluted EPS | 1.04 |
| Total Cash | 2.15B |
| Total Cash/Share | 2.57 |
| Total Debt | 2.35B |
| Total Debt/Equity | 0.12 |
| Current Ratio | 2.49 |
| Book Value Per Share | 27.63 |
| 52-Week Change | -13.75 |
| 52-Week High | 67.85 |
| 52-Week Low | 35.57 |
| Moving Average 50 Days | 50.73 |
| Moving Average 200 Days | 52.58 |
| Average Volume | 23.2M |
| Shares Outstanding | 737.9M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.13 |
| Trailing Annual Dividend Yield | 0.24 |
| Payout Ratio | 0.95 |
| Last Split Factor | 3:2 |
| Last Split Date | July 01, 2019 |